Department of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724, USA.
Biometals. 2011 Oct;24(5):875-90. doi: 10.1007/s10534-011-9441-6. Epub 2011 Mar 22.
Zinc ion homeostasis plays an important role in human cutaneous biology where it is involved in epidermal differentiation and barrier function, inflammatory and antimicrobial regulation, and wound healing. Zinc-based compounds designed for topical delivery therefore represent an important class of cutaneous therapeutics. Zinc pyrithione (ZnPT) is an FDA-approved microbicidal agent used worldwide in over-the-counter topical antimicrobials, and has also been examined as an investigational therapeutic targeting psoriasis and UVB-induced epidermal hyperplasia. Recently, we have demonstrated that cultured primary human skin keratinocytes display an exquisite sensitivity to nanomolar ZnPT concentrations causing induction of heat shock response gene expression and poly(ADP-ribose) polymerase (PARP)-dependent cell death (Cell Stress Chaperones 15:309-322, 2010). Here we demonstrate that ZnPT causes rapid accumulation of intracellular zinc in primary keratinocytes as observed by quantitative fluorescence microscopy and inductively coupled plasma mass spectrometry (ICP-MS), and that PARP activation, energy crisis, and genomic impairment are all antagonized by zinc chelation. In epidermal reconstructs (EpiDerm™) exposed to topical ZnPT (0.1-2% in Vanicream™), ICP-MS demonstrated rapid zinc accumulation, and expression array analysis demonstrated upregulation of stress response genes encoding metallothionein-2A (MT2A), heat shock proteins (HSPA6, HSPA1A, HSPB5, HSPA1L, DNAJA1, HSPH1, HSPD1, HSPE1), antioxidants (SOD2, GSTM3, HMOX1), and the cell cycle inhibitor p21 (CDKN1A). IHC analysis of ZnPT-treated EpiDerm™ confirmed upregulation of Hsp70 and TUNEL-positivity. Taken together our data demonstrate that ZnPT impairs zinc ion homeostasis and upregulates stress response gene expression in primary keratinocytes and reconstructed human epidermis, activities that may underlie therapeutic and toxicological effects of this topical drug.
锌离子动态平衡在人类皮肤生物学中起着重要作用,它参与表皮分化和屏障功能、炎症和抗菌调节以及伤口愈合。因此,设计用于局部递送的含锌化合物代表了一类重要的皮肤治疗药物。吡啶硫酮锌(ZnPT)是一种获得美国食品和药物管理局(FDA)批准的杀菌剂,在全球范围内被用于非处方局部抗菌药物,也被作为一种针对银屑病和 UVB 诱导的表皮过度增生的研究性治疗药物进行了研究。最近,我们已经证明,培养的原代人皮肤角质形成细胞对纳摩尔浓度的 ZnPT 表现出极高的敏感性,导致热休克反应基因表达和聚(ADP-核糖)聚合酶(PARP)依赖性细胞死亡的诱导(Cell Stress Chaperones 15:309-322, 2010)。在这里,我们证明 ZnPT 导致原代角质形成细胞中细胞内锌的快速积累,如通过定量荧光显微镜和电感耦合等离子体质谱法(ICP-MS)观察到的,并且 PARP 激活、能量危机和基因组损伤都被锌螯合所拮抗。在暴露于局部 ZnPT(Vanicream™中的 0.1-2%)的表皮重建体(EpiDerm™)中,ICP-MS 显示出锌的快速积累,表达谱分析显示应激反应基因(编码金属硫蛋白-2A(MT2A)、热休克蛋白(HSPA6、HSPA1A、HSPB5、HSPA1L、DNAJA1、HSPH1、HSPD1、HSPE1)、抗氧化剂(SOD2、GSTM3、HMOX1)和细胞周期抑制剂 p21(CDKN1A)的上调。ZnPT 处理的 EpiDerm™的 IHC 分析证实了 Hsp70 的上调和 TUNEL 阳性。总之,我们的数据表明,ZnPT 破坏了原代角质形成细胞和重建的人表皮中的锌离子动态平衡,并上调了应激反应基因的表达,这些活动可能是这种局部药物的治疗和毒性作用的基础。